Amphetamines, new psychoactive drugs and the monoamine transporter cycle.
about
Monoamine transporters: insights from molecular dynamics simulationsA Novel Heterocyclic Compound CE-104 Enhances Spatial Working Memory in the Radial Arm Maze in Rats and Modulates the Dopaminergic System.Making Sense of: Sensitization in SchizophreniaNon-Serotonergic Neurotoxicity by MDMA (Ecstasy) in Neurons Derived from Mouse P19 Embryonal Carcinoma CellsFrom linked open data to molecular interaction: studying selectivity trends for ligands of the human serotonin and dopamine transporterNeuropharmacology of 3,4-Methylenedioxypyrovalerone (MDPV), Its Metabolites, and Related AnalogsKinase-dependent Regulation of Monoamine Neurotransmitter Transporters.Studies of the biogenic amine transporters 15. Identification of novel allosteric dopamine transporter ligands with nanomolar potencyThe new psychoactive substances 5-(2-aminopropyl)indole (5-IT) and 6-(2-aminopropyl)indole (6-IT) interact with monoamine transporters in brain tissue.Test purchase, synthesis and characterization of 3-fluorophenmetrazine (3-FPM) and differentiation from its ortho- and para-substituted isomers.Amphetamine action at the cocaine- and antidepressant-sensitive serotonin transporter is modulated by αCaMKII.Binding Mode Selection Determines the Action of Ecstasy Homologs at Monoamine TransportersEnhanced Dopamine Release by Dopamine Transport Inhibitors Described by a Restricted Diffusion Model and Fast-Scan Cyclic Voltammetry.Phase I metabolites of mephedrone display biological activity as substrates at monoamine transporters.Direct PIP2 binding mediates stable oligomer formation of the serotonin transporterDopamine Transporter Amino and Carboxyl Termini Synergistically Contribute to Substrate and Inhibitor Affinities.Reporting Two Fatalities Associated with the Use of 4-Methylethcathinone (4-MEC) and a Review of the Literature.The effects of MDMA on socio-emotional processing: Does MDMA differ from other stimulants?New psychoactive substances: an overview on recent publications on their toxicodynamics and toxicokinetics.Neurotoxicology of Synthetic Cathinone Analogs.Application of a Combined Approach to Identify New Psychoactive Street Drugs and Decipher Their Mechanisms at Monoamine Transporters.Potential for targeting dopamine/DARPP-32 signaling in neuropsychiatric and neurodegenerative disorders.Electrogenic Binding of Intracellular Cations Defines a Kinetic Decision Point in the Transport Cycle of the Human Serotonin Transporter.Functional Rescue of a Misfolded Drosophila melanogaster Dopamine Transporter Mutant Associated with a Sleepless Phenotype by Pharmacological Chaperones.Conformational state interactions provide clues to the pharmacochaperone potential of serotonin transporter partial substrates.The N Terminus Specifies the Switch between Transport Modes of the Human Serotonin Transporter.Dual Action of Zn2+ on the Transport Cycle of the Dopamine Transporter.Occupancy of the Zinc-binding Site by Transition Metals Decreases the Substrate Affinity of the Human Dopamine Transporter by an Allosteric Mechanism.Decoding the Structure of Abuse Potential for New Psychoactive Substances: Structure-Activity Relationships for Abuse-Related Effects of 4-Substituted Methcathinone Analogs.Pharmacochaperoning in a Drosophila model system rescues human dopamine transporter variants associated with infantile/juvenile parkinsonism.Evaluation of the Abuse Potential of Novel Amphetamine Derivatives with Modifications on the Amine (NBNA) and Phenyl (EDA, PMEA, 2-APN) Sites.Overview of Monoamine Transporters.Quantitative Assessment of the Energetics of Dopamine Translocation by Human Dopamine Transporter.Allosteric modulation of human dopamine transporter activity under conditions promoting its dimerization.Effect of Dimerization on the Dynamics of Neurotransmitter:Sodium Symporters.SLC6 Transporter Folding Diseases and Pharmacochaperoning.Gβγ subunit activation promotes dopamine efflux through the dopamine transporter.Cross-Generational trans Fat Consumption Favors Self-Administration of Amphetamine and Changes Molecular Expressions of BDNF, DAT, and D1/D2 Receptors in the Cortex and Hippocampus of Rats.A kinetic account for amphetamine-induced monoamine release.Structure-Activity Relationships of Substituted Cathinones, with Transporter Binding, Uptake, and Release.
P2860
Q26777242-D8C7A30F-A8E4-4BB7-8ABA-9A113F9858E0Q27321436-236FBE51-CBA9-498B-B4FD-A8EFE1BA3BF1Q28077939-C36669A1-8EE5-458C-BC1A-B884A6F9CABBQ28553620-67F067AD-C2C7-445C-83E8-3FA9A595DBC4Q28596136-F0B54383-8D8C-44B2-B43D-540AA343C2EDQ33566201-EB93AD05-F056-49DF-BEDA-432EFFCCA8ECQ34161514-52990835-F049-40C0-9C85-DB4678CF93B4Q34467830-BA5641A9-5D9C-4A5B-A137-11720C5D68B0Q34493739-93131F2E-95D5-41E8-AC6D-DDA55CC4444CQ34510784-B67AAD7B-F1EB-46B7-9BC7-967D8AB801A9Q35649527-ABF66272-6F1F-4880-81C9-217FF4297F8FQ36432395-20B21D81-F31B-4078-A6A1-B5317E22B232Q37008883-1907B64E-C50F-4219-8F65-1A067C413BB0Q37161370-8260AD17-08F7-4590-ACEE-D449D3D95810Q37598409-0A40E727-C0B4-4A9F-9694-E35EE7ACB9E1Q38725778-CC94576E-2B36-4619-BE1F-0A88B0C22EDBQ38894030-DB6DBD46-24EF-4D41-8442-48A80D03876AQ38937390-8DA5C1AB-05A5-4B64-AAA5-971DA0429B33Q38963846-7984C01C-7519-483E-9151-0B868A13BD54Q38983638-C99A8C46-6A70-4DF4-B2A7-78502E5875D2Q39057330-A925646E-0847-4C16-B998-1C4F7486DD70Q39067400-651196AD-A746-4306-8677-46501CFDF2E0Q39274385-AD59B71B-26C3-427A-8C80-B2E45D81883AQ41549350-41C736C9-C23D-4BAF-9733-E7A295A31BB2Q41861390-E6C9655B-C456-49AF-B436-AAB79FC4E134Q41970582-10869DE4-241F-44F1-B652-6FDB44669436Q42249280-2C892D3A-EAD5-4219-B397-35A015F16D87Q42315857-8127CE70-F0EB-4992-B386-5417683B90B4Q45044131-FF8EF0BC-9391-4FD1-8446-4FE756D9CF63Q47127983-59C1DABE-5C86-4AC3-B4E4-1504D84C9A61Q47137534-3409D12A-42C4-48B5-8C72-407D578752D8Q47271566-9E7A8C74-DC03-4516-B06D-0D04D6CB04F5Q47302876-831F9274-04FD-4653-AC99-08AC0EDC10E1Q47565964-2AFEE61F-3F5B-4F5D-B33B-7EDB1536CCCFQ47566777-89648008-C246-496B-BFA4-1750FF395FEBQ47585152-143EAF3B-ADB5-416D-85D3-956422C175C0Q47624474-30518FD4-F94F-435D-815C-5DA685121DC4Q47669070-81A2CB81-69DC-488E-914F-6E511EE9DCBAQ50035451-7D03B6FD-4940-4D67-8EE0-7904010D52B5Q50300878-A3C4DD3F-84A4-4281-94A8-A8EA72EA77D3
P2860
Amphetamines, new psychoactive drugs and the monoamine transporter cycle.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Amphetamines, new psychoactive drugs and the monoamine transporter cycle.
@ast
Amphetamines, new psychoactive drugs and the monoamine transporter cycle.
@en
type
label
Amphetamines, new psychoactive drugs and the monoamine transporter cycle.
@ast
Amphetamines, new psychoactive drugs and the monoamine transporter cycle.
@en
prefLabel
Amphetamines, new psychoactive drugs and the monoamine transporter cycle.
@ast
Amphetamines, new psychoactive drugs and the monoamine transporter cycle.
@en
P2860
P921
P1476
Amphetamines, new psychoactive drugs and the monoamine transporter cycle
@en
P2093
Harald H Sitte
Michael Freissmuth
P2860
P356
10.1016/J.TIPS.2014.11.006
P577
2014-12-23T00:00:00Z